Acute hemifacial ischemia as a late complication of carotid stenting by M. Domanin et al.
From th
Milan
Neur
Polic
Author
Corresp
Com
20122
The edi
disclo
manu
2468-4
 2017
Surge
creat
http://dAcute hemifacial ischemia as a late complication of carotid
stentingMaurizio Domanin, MD,a,b Maurizio Isalberti, MD,c Silvia Romagnoli, MD,b Antonio Rolli, MD,b and
Simona Sommaruga, MD,b Milan, ItalyConcerns about carotid artery stenting (CAS) center primarily on procedural complications like acute occlusion,
stroke, and long-term intrastent restenosis. External carotid artery (ECA) thrombosis is observed during CAS follow-
up, but it often remains asymptomatic or, at worst, results in jaw claudication. We report here a case of late occlusion
of the ECA after CAS with symptoms of acute homolateral facial ischemia as well as pain, cyanosis, tongue
numbness, and skin coldness. The patient was submitted to local thrombolysis and balloon angioplasty with
regression of symptoms after recanalization. With this report, we add a caveat about blockage of the ECA ostium
during CAS. (J Vasc Surg Cases 2017;3:83-6.)Fig 1. Cyanosis and patchy discoloration of the skin of the
right hemiface secondary to external carotid artery (ECA)
thrombosis.Because of the steady pace of advances in stent tech-
nology and the increasing experience of vascular special-
ists, carotid artery stenting (CAS) is challenging carotid
endarterectomy (CEA) as a therapy option for stenosis.
Major concerns about CAS include periprocedural stroke,
secondary to embolization or stent thrombosis, and late
development of intrastent restenosis. In contrast to sur-
gery, CAS ensures the artery’s patency by crushing and
stabilizing, as a scaffolding, the ﬂattened plaque, but it
does not enable a decrease in the bulk of the atheroma-
tous plaque. Consequently, the external carotid artery
(ECA), which represents the main collateral branch for
ipsilateral cerebral perfusion, is often covered by the
metal struts of the stent. This contributes to a worsening
of ECA perfusion that can evolve into thrombosis and
cause unexpected complications, such as jaw claudica-
tion1 or facial ischemia, as in the case presented here.
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CASE REPORT
A 64-year-old man arrived at the emergency department of our
institution at 6:00 PM. Symptoms started at 3:00 PM with
increasing pain localized in the lingual and masseter regions.
Pain rapidly worsened and extended to the zygomatic and
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x.doi.org/10.1016/j.jvscit.2016.12.004cyanosis, coldness, and paresthesias of the right hemiface
(Fig 1). His medical history was signiﬁcant for smoking, hypercho-
lesterolemia, essential hypertension, and diabetes. He had
undergone left CEA in another hospital in 2008 for left asymp-
tomatic carotid stenosis >70%. He refused CEA of a severe
contralateral carotid stenosis in 2010 because of his distressing
experience relative to locoregional anesthesia during the ﬁrst
intervention. He was submitted to right CAS with a 7.0- to
10.0-mm-diameter/40-mm-long self-expanding nitinol stent
(Cristallo; Medtronic, Fridley, Minn), consequently to dual anti-
platelet therapy for 30 days, and thereafter to aspirin 100 mg
once a day according to guidelines for antiplatelet therapy after
CAS.2 The procedure went well, and the patient underwent
Doppler ultrasound (DUS) follow-up regularly, with no detection
of post-CEA restenosis on the left or intrastent restenosis on the
right. At the time of the last follow-up, 4 months before facial
ischemia, peak systolic velocities (PSVs) were, respectively, 90
and 100 cm/s; both of the ECAs, as often happens after CAS,
were just described as “patent” without any supplemental
information about velocities or ultrasound waveform.
He was taking aspirin 100 mg once daily, rosuvastatin 20 mg
daily, atenolol 50 mg daily, valsartan/hydrochlorothiazide 160/83
Fig 2. a, Selective right carotid arteriography. Complete occlusion of the right external carotid artery (ECA) with
conserved patency of the superior thyroidal artery (STA) and partial intrastent restenosis of the internal carotid
artery (ICA). VA, Vertebral artery. b, Initial partial recanalization of the ECA after local thrombolysis and passage
of the 0.035-inch hydrophilic guidewire and diagnostic catheter across the stent cells.
84 Domanin et al Journal of Vascular Surgery Cases and Innovative Techniques
June 201712.5 mg daily, repaglinide three times a day, and acarbose 50 mg
twice a day. On examination, blood pressure was 140/80mmHg,
heart rate was 110 beats/min, and oxygen saturation was 98% on
room air. DUS showed the patency of the right carotid axis with
amild intrastent restenosis and occlusion of the ECA. No absolute
or relative contraindications to thrombolytic therapy were found.
Throughout femoral access, the right common carotid artery
(CCA) was catheterized with a 5F diagnostic catheter; angiog-
raphy conﬁrmed occlusion of the ECA with a weak supply ﬂow
inversion, through the occipital artery by the homolateral verte-
bral artery (Fig 2, a). After some attempts to cross the ECA occlu-
sion with microcatheters, the blockage was reopened by
moving the diagnostic catheter and guidewire across the stent
cells. A 6F guiding catheter (Neuron; Penumbra, Alameda, Calif)
was then positioned close to the ECA’s ostium, and by means of
a 1.7F microcatheter (Excelsior SL-10; Stryker Neurovascular,
Fremont, Calif), a bolus of 200,000 units of urokinase was
injected (Fig 2, b). Angioplasty was then performed using a
2-mm-diameter  20-mm-long microballoon catheter (Ultra-
soft SV; Boston Scientiﬁc, Maple Grove, Minn), obtaining almost
immediate relief from symptoms. The microcatheter was left
in the ECA to allow continuous infusion of 50,000 IU/h urokinase
and heparin 4000 IU for 12 hours and for ﬁnal angiographic con-
trol (Fig 3, a). No complications occurred, and the postoperative
course was uneventful. The patient was discharged fully asymp-
tomatic (Fig 3, b) after 2 days of double antiplatelet therapy
(aspirin 100 mg and clopidogrel 75 mg daily). At discharge and
during quarterly DUS follow-up, we have reported right CCAPSV of 80 cm/s, right internal carotid artery (ICA) PSV of
90 cm/s, right ICA/CCA PSV ratio of 1.12, and right ECA PSV of
150 cm/s with a residual thin layer of thrombus at its origin.
DISCUSSION
The ECA mainly supplies blood to the face, neck,
tongue, maxilla, and scalp through a rich collateral
network of side and terminating branches that together
may ensure the half-face’s blood supply when ECA
occlusion occurs.3
Furthermore, the ECA is a fundamental contributor to
the cerebral ﬂow supply of the ipsilateral hemisphere in
case of ICA steno-occlusion.4 ECA collateral circulation
reduces or even cancels symptoms of cerebral ischemia,
and guidelines have suggested that surgeons should also
meticulously remove the plaque from the ECA’s ostium,
avoiding its occlusion.5
Stents are rapidly evolving, and CAS today competes
with CEA as a treatment option for patients with carotid
stenosis, considering the worldwide increase in the num-
ber of procedures performed. Nevertheless, the best
management of carotid stenosis is still under discussion.
Major concerns about CAS revolve around perioperative
stent thrombosis and plaque embolization and intra-
stent restenosis as late complications.6
The fate of the ECA in CAS has always been considered a
less important issue, notwithstanding its fundamental role
in cerebral ﬂow supply to the ipsilateral hemisphere.7,8
Fig 3. a, Final result after local thrombolysis and angioplasty of the external carotid artery (ECA). ICA, Internal
carotid artery. b, Recovery from hemiface ischemia obtained after revascularization.
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plaque starts from the distal CCA and hence the stent
needs to “jail” its origin, thereby reducing ﬂow in the ECA,
inducing conditions of low wall shear stress and promot-
ing myointimal hyperplasia.9,10 Faster progression of
atherosclerotic disease in the ipsilateral ECA after CAS
compared with the contralateral one has been reported.11
Other issues could be the lack of plaque debulking from
the ECA’s ostium or pressure of atheromatous materials
in the ECA during the stent’s deployment.12,13
Thrombosis of the ECA usually develops asymptomati-
cally. Symptoms of the ECA’s occlusion typically are the
masseter’s intermittent claudication after a few minutes
of chewing food.1,3 Cold-triggered neck pain, facial pain,
and cyanosis and necrosis of ear, preauricular region,
and tongue have also been described.13-15
Late clinical complications of CAS related to ECA throm-
bosis have already been reported. Chen et al described a
case of secondary severe malnutrition secondary to jaw
claudication, treated by means of eversion CEA.1 A few
cases of iatrogenic facial ischemia after ECA thrombosis
have been observed after procedures of arteriovenous
malformation embolization,16 intra-arterial hyaluronic
acid injection,17 or endodontic calcium hydroxide injec-
tion,18 but those complications always involved distal ter-
minal branches of the ECA.
In the case reported here, the whole ECA, from its origin
extending to all the collateral branches, was affected by
thrombosis. Postoperative carehasbeen free fromcompli-
cations for 5 years; the patient received appropriate aspirintherapy, and no coagulopathies were observed. Moreover,
collateral circulation had to be optimal, considering previ-
ous and still patent contralateral CEA. We opted for
prompt ECA recanalization with local thrombolysis and
angioplasty because of the fear of unpredictable out-
comes, ranging fromspontaneous recovery fromischemia,
thanks to the uncertain collateral network’s development,
to the prevented and more probable evolution toward
tongue, hard palate, or hemifacial skin ischemia and ne-
crosis. We preferred to keep the ECA’s endarterectomy
with, at worst, “en bloc” stent removal, considered an alter-
native option in case of failure of thrombolysis or recur-
rences, given the high risk of arterial wall damage.
This report should be considered a caveat to all vascular
specialists, in planning for CAS intervention and during
follow-up, to perform a more careful analysis of preoper-
ative localization of carotid plaque and the condition of
the ECA. The current use of antiplatelet therapy after
CAS is heterogeneous.19,20 It may be reasonable to sug-
gest restarting of clopidogrel or even double antiplatelet
therapy protection if thrombus growth or residual steno-
sis is observed in the ECA during DUS follow-up.
The authors acknowledge Edward Kiegle for his revision
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